JBIO vs BIIB: Which Stock is Better?
Side-by-side comparison of Jade Biosciences Inc and Biogen Inc in 2026
JBIO
Jade Biosciences Inc
$22.85
BIIB
Biogen Inc
$177.35
Key Metrics Comparison
| Metric | JBIO | BIIB | Winner |
|---|---|---|---|
| Market Cap | $1.13B | $26.03B | BIIB |
| P/E Ratio | N/A | 20.15 | BIIB |
| EPS (TTM) | $N/A | $8.80 | BIIB |
| Revenue Growth | 0.0% | -0.1% | BIIB |
| Gross Margin | 0.0% | 78.9% | BIIB |
Analyze JBIO
Full quant analysis
Analyze BIIB
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is JBIO or BIIB a better investment?
Comparing JBIO and BIIB: Jade Biosciences Inc has a market cap of $1.13B while Biogen Inc has $26.03B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between JBIO and BIIB?
JBIO (Jade Biosciences Inc) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: JBIO or BIIB?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: JBIO or BIIB?
JBIO has higher revenue growth at 0.0% vs -0.1% for BIIB.
Which company is more profitable: JBIO or BIIB?
Biogen Inc (BIIB) has higher gross margins at 78.9% compared to 0.0% for JBIO.
Which is the larger company: JBIO or BIIB?
Biogen Inc (BIIB) is larger with a market cap of $26.03B compared to $1.13B for JBIO.
Should I buy JBIO or BIIB in 2026?
Both JBIO and BIIB have investment merit. JBIO trades at $22.85 while BIIB trades at $177.35. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between JBIO and BIIB stock?
Key differences: Market Cap ($1.13B vs $26.03B), P/E Ratio (N/A vs 20.2x), Revenue Growth (0.0% vs -0.1%), Gross Margin (0.0% vs 78.9%).